X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6) 6
pharmacokinetics (6) 6
pharmacology & pharmacy (5) 5
adult (4) 4
female (4) 4
humans (4) 4
male (4) 4
pharmacology (4) 4
hemodialysis (3) 3
impairment (3) 3
middle aged (3) 3
renal function (3) 3
safety (3) 3
aged (2) 2
analysis (2) 2
care and treatment (2) 2
dialysis (2) 2
drug dosages (2) 2
kidney-disease (2) 2
pharmacodynamics (2) 2
renal dialysis (2) 2
renal impairment (2) 2
special populations (2) 2
studies (2) 2
absorption - drug effects (1) 1
acetaminophen - pharmacokinetics (1) 1
adenosine - administration & dosage (1) 1
adenosine - analogs & derivatives (1) 1
adenosine - blood (1) 1
adenosine - pharmacokinetics (1) 1
aged, 80 and over (1) 1
alfacalcidol (1) 1
antibiotics (1) 1
antral motility (1) 1
area under curve (1) 1
biomedicine (1) 1
blood platelets - drug effects (1) 1
blood platelets - metabolism (1) 1
body mass (1) 1
body mass index (1) 1
body size (1) 1
breast cancer (1) 1
calcifediol (1) 1
calciferol metabolism (1) 1
calcium (1) 1
calcium - blood (1) 1
cefiderocol (1) 1
cephaloridine (1) 1
cephalosporin (1) 1
cephalosporins (1) 1
cephalosporins - adverse effects (1) 1
cephalosporins - blood (1) 1
cephalosporins - pharmacokinetics (1) 1
cephalosporins - urine (1) 1
chronic kidney failure (1) 1
clinical trials (1) 1
confidence intervals (1) 1
creatinine (1) 1
cross-over studies (1) 1
diarrhea (1) 1
digestive, oral, and skin physiology (1) 1
dosage and administration (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug interaction (1) 1
drug interactions (1) 1
elevation (1) 1
eluxadoline (1) 1
energy-intake (1) 1
epidemiology (1) 1
esrd (1) 1
gastric emptying (1) 1
gastric emptying - drug effects (1) 1
gastroenterology (1) 1
gastroenterology & hepatology (1) 1
gastrointestinal agents - administration & dosage (1) 1
gastrointestinal agents - pharmacology (1) 1
gene-expression (1) 1
glp-2 analog (1) 1
glucagon-like peptide-2 (1) 1
gram-negative bacteria (1) 1
guidelines (1) 1
gw572016 (1) 1
half-life (1) 1
hepatic impairment (1) 1
homeostasis (1) 1
hormone replacement therapy - methods (1) 1
hypoparathyroidism (1) 1
hypoparathyroidism - drug therapy (1) 1
impact (1) 1
in-vivo (1) 1
infusion (1) 1
inhibitor (1) 1
injections, subcutaneous (1) 1
internal medicine (1) 1
intestinal failure (1) 1
intravenous administration (1) 1
involvement (1) 1
irritable bowel syndrome (1) 1
irritable-bowel-syndrome (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Pharmacology, ISSN 0091-2700, 10/2019, Volume 59, Issue 10, pp. 1379 - 1383
Lapatinib, a tyrosine kinase inhibitor, is approved for the treatment of breast cancer. The literature shows that it is metabolized by CYP3A4 and eliminated... 
ESRD | lapatinib | hemodialysis | pharmacokinetics | renal impairment | KIDNEY-DISEASE | IMPACT | METABOLISM | GW572016 | PHARMACOLOGY & PHARMACY | INHIBITOR | Tyrosine | Renal function | Hemodialysis | Drug interactions | Impairment | Clinical trials | Breast cancer | Pharmacology | Kinases | Drug interaction | Dialysis | Kidney diseases | Pharmacokinetics | Protein-tyrosine kinase | Drug dosages | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1280 - 1280
Abstract Introduction: The iron transporter ferroportin is a membrane protein expressed in enterocytes that absorb dietary iron, macrophages of the spleen and... 
Journal Article
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 9/2018, Volume 74, Issue 9, pp. 1141 - 1148
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.